Class / Patent application number | Description | Number of patent applications / Date published |
424531000 | Serum | 12 |
20100112082 | Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides - The present invention provides BoNT/B peptides, BoNT/B peptide compositions, tolerogizing compositions, immune response inducing compositions, as well as methods of determining immunoresistance to botulinum toxin therapy in an individual, methods of treating immunoresistance to botulinum toxin therapy in an individual, methods of reducing anti-botulinum toxin antibodies in an individual and methods of inducing a BoNT/B immune response an individual. | 05-06-2010 |
20110244053 | Use a goat serum for veterinary treatment - Methods for veterinary treatment of mammals are described, for treatment of conditions having an inflammatory component. The methods are particularly suited to treatment of cats, dogs, or horses. | 10-06-2011 |
20110318424 | METHODS FOR PROLONGING VIABILITY OF CONE CELLS USING MODULATORS OF THE MAMMALIAN TARGET OF RAPAMYCINE (mTOR) - The present invention is directed to the use of modulators of the mammalian target of rapamycine (mTOR) pathway, glucose and/or glucose enhancers for treating retinal disorders and, in particular, for prolonging the viability of cone cells. | 12-29-2011 |
20120294951 | USE OF GOAT SERUM FOR VETERINARY TREATMENT - Methods for veterinary treatment of mammals are described, for treatment of conditions having an inflammatory component. The methods are particularly suited to treatment of cats, dogs, or horses. | 11-22-2012 |
20130039991 | Elimination of N-Glycolylneuraminic Acid From Animal Products For Human Use - The application is in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism and antigenicity. More particularly, the invention is related to a method to produce Neu5Gc-free animals and products therefrom comprising disrupting the CMAH gene and thereby reducing or eliminating Neu5Gc from biological material of non-humans. | 02-14-2013 |
20130230600 | THERAPEUTIC AGENT - Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions. | 09-05-2013 |
20130243880 | PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARING SAME - An object of the present invention is to provide a pharmaceutical composition comprising an enzyme-treated human serum which is useful for treatment and prevention of diseases such as a cancer and an infectious disease, and a method of preparing the same. The present invention relates to a method of preparing a pharmaceutical composition comprising an enzyme-treated human serum, comprising a step of bringing the human serum into contact with β-galactosidase and, to a pharmaceutical composition comprising an enzyme-treated human serum obtained by the preparation method. | 09-19-2013 |
20140023720 | ENHANCED AUTOLOGOUS GROWTH FACTOR PRODUCTION AND DELIVERY SYSTEM - Systems and methods for producing enhanced blood serum with concentrated growth factors and/or prophylactically and therapeutically active proteins. An autologous blood product is obtained from a donor and then incubated into a containment device (sterile container) that includes a source of cells or tissue (for example, autologous, allogeneic, or xenographic tissue, or combinations thereof). The cells from the injected fluid (autologous blood product) interact/incubate with the source of cells or tissue inside the containment device, to produce a serum that is loaded with autologous proteins, growth factors, and cytokines. The autologous blood product may be a fluid and/or composition that includes blood, whole blood, autologous conditioned plasma, platelet-rich plasma, platelet-poor plasma, bone marrow aspirate, bone marrow concentrate and stem cells, among others, and combinations thereof. | 01-23-2014 |
20140044798 | Elimination of N-Glycolylneuraminic Acid From Animal Products For Human Use - The application is in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism and antigenicity. More particularly, the invention is related to a method to produce Neu5Gc-free animals and products therefrom comprising disrupting the CMAH gene and thereby reducing or eliminating Neu5Gc from biological material of non-humans. | 02-13-2014 |
20140105998 | TREATMENT OF DISEASES - Methods of treatment of various non-demyelinating and demyelinating neural disorders are provided, comprising administering a serum composition obtained from a goat after challenge with an immunogen. Also provided are methods of treatment of certain autommune disorders using such a composition. | 04-17-2014 |
20150064270 | COMPOSITION AND METHOD FOR EFFECTIVE LEAN BODY MASS GAIN - This invention provides compositions comprising serum protein isolate, whey protein concentrate, and whey protein isolate. The invention also provides methods for increasing lean body mass in a human, comprising administering to the human an effective amount of a composition comprising serum protein isolate and whey protein concentrate. | 03-05-2015 |
20160101131 | TREATMENT OF DISEASES - Provided are methods for the treatment of various neural disorders including non-demyelinating neural disorders, such as Alzheimer's disease, as well as methods for the treatment of various autoimmune or immune-mediated disorders, such as scleroderma. Also provided are methods for restoring or improving one or more nerve functions, such as neural transmission, in a human with a neural disorder, such as a non-demyelinating neural disorder. Each of these methods comprise the administration of a serum composition obtained from a goat after challenge with an immunogen, in particular HIV or a lysate thereof. | 04-14-2016 |